BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31091859)

  • 1. Current Status of and Perspectives on Cervical Cancer Screening in Korea.
    Lim SC; Yoo CW
    J Pathol Transl Med; 2019 Jul; 53(4):210-216. PubMed ID: 31091859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Liquid-Based Cytology and Conventional Papanicolaou Smear for Cervical Cancer Screening: An Experience From Pakistan.
    Hashmi AA; Naz S; Ahmed O; Yaqeen SR; Irfan M; Asif MG; Kamal A; Faridi N
    Cureus; 2020 Dec; 12(12):e12293. PubMed ID: 33520497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of liquid-based cytology with conventional Papanicolaou smears in cervical dysplasia diagnosis.
    Haghighi F; Ghanbarzadeh N; Ataee M; Sharifzadeh G; Mojarrad JS; Najafi-Semnani F
    Adv Biomed Res; 2016; 5():162. PubMed ID: 27995101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.
    Kang M; Ha SY; Cho HY; Chung DH; Kim NR; An J; Lee S; Seok JY; Jeong J
    J Pathol Transl Med; 2020 Jan; 54(1):112-118. PubMed ID: 31964113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
    Karnon J; Peters J; Platt J; Chilcott J; McGoogan E; Brewer N
    Health Technol Assess; 2004 May; 8(20):iii, 1-78. PubMed ID: 15147611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening: A never-ending developing program.
    Comparetto C; Borruto F
    World J Clin Cases; 2015 Jul; 3(7):614-24. PubMed ID: 26244153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liquid-based cervical cytology ThinPrep screening in Hungary].
    Bak M; Séberné Éll M; Bóka M; Veleczki Z; Nyári T; Pete I; Szentirmay Z
    Orv Hetil; 2014 May; 155(18):708-14. PubMed ID: 24776385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cervical cancer: screening, progress and perspectives].
    Monsonego J
    Presse Med; 2007 Jan; 36(1 Pt 2):92-111. PubMed ID: 17296477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present standards for cervical cancer screening.
    O'Meara AT
    Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.
    Barodawala SM; Chadha K; Kavishwar V; Murthy A; Shetye S
    Diagn Cytopathol; 2019 May; 47(5):374-381. PubMed ID: 30468313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of conventional and SurePath liquid-based cervicovaginal cytology: A study of 140 cases.
    Sharma J; Toi PCh; Siddaraju N; Sundareshan M; Habeebullah S
    J Cytol; 2016; 33(2):80-4. PubMed ID: 27279683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between Siriraj liquid-based and conventional cytology for detection of abnormal cervicovaginal smears: a split-sample study.
    Laiwejpithaya S; Rattanachaiyanont M; Benjapibal M; Khuakoonratt N; Boriboonhirunsarn D; Laiwejpithaya S; Sangkarat S; Wongtiraporn W
    Asian Pac J Cancer Prev; 2008; 9(4):575-80. PubMed ID: 19256741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
    Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
    Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Korean guideline for cervical cancer screening.
    Min KJ; Lee YJ; Suh M; Yoo CW; Lim MC; Choi J; Ki M; Kim YM; Kim JW; Kim JH; Park EW; Lee HY; Lim SC; Cho CH; Hong SR; Dang JY; Kim SY; Kim Y; Lee WC; Lee JK
    J Gynecol Oncol; 2015 Jul; 26(3):232-9. PubMed ID: 26197860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
    Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
    Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.